RSVpredict: An Online Tool to Calculate the Likelihood of Respiratory Syncytial Virus Infection in Children Hospitalized With Acute Respiratory Disease.


Journal

The Pediatric infectious disease journal
ISSN: 1532-0987
Titre abrégé: Pediatr Infect Dis J
Pays: United States
ID NLM: 8701858

Informations de publication

Date de publication:
07 2019
Historique:
pubmed: 7 2 2019
medline: 23 4 2020
entrez: 7 2 2019
Statut: ppublish

Résumé

Respiratory syncytial virus (RSV) is the leading cause of acute lower respiratory tract infection in young children. Early detection of RSV infection can avoid unnecessary diagnostic and therapeutic intervention and is required to prevent the nosocomial spread of RSV infection in pediatric hospitals. We developed a web tool to calculate the probability of RSV infection in children hospitalized with acute respiratory tract infection (ARTI) (RSVpredict). During winter seasons 2014/2015 to 2017/2018, 1545 children hospitalized with clinical symptoms of ARTI at the University Hospital Heidelberg/Germany were prospectively included. Medical information was reported on a standardized data sheet, and nasopharyngeal swabs were obtained for multiplex real-time polymerase chain reaction analyses. We applied logistic regression to develop a prediction model and developed a web-based application to predict the individual probability of RSV infection. Duration of clinical symptoms ≥2 days on admission, calendar month of admission, admission for lower respiratory tract infection, the presence of cough and rale and younger age were associated with RSV infection (P < 0.05). Those data were included in the prediction model (RSVpredict, https://web.imbi.uni-heidelberg.de/rsv/). RSVpredict is a web-based application to calculate the risk of RSV infection in children hospitalized with ARTI. The prediction model is based on easily accessible clinical symptoms and predicts the individual probability of RSV infection risk immediately. Pediatricians might use the RSVpredict to take informed decisions on further diagnostic and therapeutic intervention, including targeted RSV testing in children with relevant RSV infection risk.

Sections du résumé

BACKGROUND
Respiratory syncytial virus (RSV) is the leading cause of acute lower respiratory tract infection in young children. Early detection of RSV infection can avoid unnecessary diagnostic and therapeutic intervention and is required to prevent the nosocomial spread of RSV infection in pediatric hospitals. We developed a web tool to calculate the probability of RSV infection in children hospitalized with acute respiratory tract infection (ARTI) (RSVpredict).
METHODS
During winter seasons 2014/2015 to 2017/2018, 1545 children hospitalized with clinical symptoms of ARTI at the University Hospital Heidelberg/Germany were prospectively included. Medical information was reported on a standardized data sheet, and nasopharyngeal swabs were obtained for multiplex real-time polymerase chain reaction analyses. We applied logistic regression to develop a prediction model and developed a web-based application to predict the individual probability of RSV infection.
RESULTS
Duration of clinical symptoms ≥2 days on admission, calendar month of admission, admission for lower respiratory tract infection, the presence of cough and rale and younger age were associated with RSV infection (P < 0.05). Those data were included in the prediction model (RSVpredict, https://web.imbi.uni-heidelberg.de/rsv/). RSVpredict is a web-based application to calculate the risk of RSV infection in children hospitalized with ARTI. The prediction model is based on easily accessible clinical symptoms and predicts the individual probability of RSV infection risk immediately.
CONCLUSIONS
Pediatricians might use the RSVpredict to take informed decisions on further diagnostic and therapeutic intervention, including targeted RSV testing in children with relevant RSV infection risk.

Identifiants

pubmed: 30724836
doi: 10.1097/INF.0000000000002283
doi:

Types de publication

Journal Article

Langues

eng

Sous-ensembles de citation

IM

Pagination

678-681

Auteurs

Britta Manuel (B)

From the German Center for Infection Research (DZIF), Heidelberg partner site, Germany.
Center for Infectious Diseases, Virology.

Matthes Hackbusch (M)

Institute of Medical Biometry and Informatics (IMBI).

Julia Tabatabai (J)

From the German Center for Infection Research (DZIF), Heidelberg partner site, Germany.
Center for Infectious Diseases, Virology.
Center for Childhood and Adolescent Medicine (General Pediatrics), University Hospital Heidelberg, Germany.

Johannes Hoos (J)

From the German Center for Infection Research (DZIF), Heidelberg partner site, Germany.
Center for Childhood and Adolescent Medicine (General Pediatrics), University Hospital Heidelberg, Germany.

Rebecca Peters (R)

From the German Center for Infection Research (DZIF), Heidelberg partner site, Germany.
Center for Infectious Diseases, Virology.
Center for Childhood and Adolescent Medicine (General Pediatrics), University Hospital Heidelberg, Germany.

Sarah Valerie Schnee (S)

From the German Center for Infection Research (DZIF), Heidelberg partner site, Germany.
Center for Infectious Diseases, Virology.

Clara Marlene Ihling (C)

From the German Center for Infection Research (DZIF), Heidelberg partner site, Germany.
Center for Infectious Diseases, Virology.

Paul Schnitzler (P)

Center for Infectious Diseases, Virology.

Johannes Pfeil (J)

From the German Center for Infection Research (DZIF), Heidelberg partner site, Germany.
Center for Childhood and Adolescent Medicine (General Pediatrics), University Hospital Heidelberg, Germany.

Articles similaires

[Redispensing of expensive oral anticancer medicines: a practical application].

Lisanne N van Merendonk, Kübra Akgöl, Bastiaan Nuijen
1.00
Humans Antineoplastic Agents Administration, Oral Drug Costs Counterfeit Drugs

Smoking Cessation and Incident Cardiovascular Disease.

Jun Hwan Cho, Seung Yong Shin, Hoseob Kim et al.
1.00
Humans Male Smoking Cessation Cardiovascular Diseases Female
Humans United States Aged Cross-Sectional Studies Medicare Part C
1.00
Humans Yoga Low Back Pain Female Male

Classifications MeSH